Possible clinical effects of the interaction of hemodialysis membranes with adhesion proteins  by Baumgartner-Parzer, Sabina M. et al.
Kidney International, VoL 47 (1995), pp. 1115—1120
Possible clinical effects of the interaction of hemodialysis
membranes with adhesion proteins
SABINA M. BAUMGARTNER-PARZER, ULRICH T. SEYFERT, and CHRISTINE MI'imR
Department of Internal Medicine III, Division of Endocrinology and Metabolism, and Clinical Institute of Medical Chemistry and Laboratoty Diagnostics,
University of Vienna, Vienna, Austria; and Department of Clinical Haemostaseology and Transfusion Medicine, University Hospital of Hombu,g/Saar,
Homburg, Gennany
Possible clinical effects of the interaction of hemodialysis membranes
with adhesion proteins. In this study data obtained in an in vitro
hemodialysis model are related to various parameters measured in
patients' plasma during hemodialysis in a clinical crossover study. In vitro,
blood from healthy volunteers was dialyzed under standardized conditions
using the capillaries Fresenius MTS C (Cuprophane) and Hospal AN 69
(Polyacrylonitrile). Following dialysis, surface bound proteins were eluted
with saline, I M Tris and 2% SDS, and analyzed by immunoblotting.
Depending on the capillaiy, different protein patterns could be identified
in the eluates. Intact forms of adhesion proteins were predominantly
(fibrinogen) or exclusively (vitronectin) found in PA eluates. In contrast,
low molecular weight products of fibrinogen as well as high molecular
weight components containing antithrombin III (AT III) were present in
CP eluates. Their presence may reflect fibrinolytic and procoagulatory
activity during dialysis with CP capillaries. A microscopic investigation of
CP membranes demonstrated fibrin lined platelet conglomerates. In the
plasmas of patients dialyzed with CP capillaries high D-Dimer concentra-
tions were found. We also noticed that during dialysis with PA membranes
less heparin was consumed than during dialysis with CP membranes. Our
study showed a good correlation of the observations in the in vitro system
and the measurements in patient samples.
Hemodialysis is associated with undesired side effects, caused
by interactions between blood elements and hemodialysis mem-
branes. The deposition of heterogeneous protein films on foreign
surfaces has been shown to be of critical importance for subse-
quent events such as the activation of cells, the initiation of blood
coagulation or the activation of the complement system [1—51. In
spite of numerous investigations, evaluation of the biocompatibil-
ity of hemodialysis membranes is difficult, due to the fact that
many different in vivo and in vitro test systems are used [6—91.
The goal of our study was the collection of data which could
contribute to a better understanding of the events occurring on
hemodialysis membranes in contact with blood. In a standardized
in vitro hemodialysis model, protein adsorption from heparinized
whole blood onto two different dialysis capillaries, Cuprophane
(CP) and Polyacrylonitrile (PA), was investigated. In parallel
experiments, heparin and D-Dimer concentrations in patients'
plasmas after hemodialysis with these capillaries were measured.
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Methods
Patient study
Ten patients (6 female, 4 male, aged between 20 and 65 years)
undergoing maintainance hemodialysis (hemodialysis duration
between 0.5 and 10 years) because of chronic renal insufficiency,
gave informed consent to participate in this crossover study. The
patients had stable hemodialysis conditions: Hb > 6.5 g/liter,
platelet counts > 100,000/mm3, Quick > 70%, and APT!',
thrombin time and fibrinogen concentrations within normal
ranges. Patients were excluded from the study if they had severe
cardiovascular or liver diseases, arterial hypotension, autonomic
insufficiency, serum potassium > 6 mmol/liter, were receiving
erythropoietin, or therapies influencing platelet aggregation.
In the study two dialyzing systems were used: (a) the Fresenius
MTS C capillary dialyzer (1.3 m2 Cuprophane; CP) and a Drake
Willock machine (Model #4215/16); and (b) the AN 69 dialyzing
system (1.3 m2 Polyacrylonitrile; PA), using a Monitral Dialysis
Machine.
Blood flow was maintained at 150 to 200 mi/mm, dialysate
(bicarbonate, SW 56 BC; Schiwa, Glahndorf, Germany) flow at
500 mI/mm, and the ultrafiltration rate was kept constant through-
out the study. Weight loss was 1.5 0.5 kg during hemodialysis.
Anticoagulation was achieved with unfractionated heparin (bolus
50 U heparin/kg body wt, intravenously; 1000 U/hr heparin were
administered during hemodialysis).
Measurement of blood parameters
Before dialysis (TO), after 20 minutes (Ti), 120 minutes (T2)
and 240 to 270 minutes (end of dialysis, T3) hemoglobin, etyth-
rocyte count and leukocyte count were determined by Hemolog
8/90-Technikon. Platelet counts were measured by a 147 C
platelet analyzer (Dilab, Karisruhe, Germany).
Throughout the study the prothrombin time, activated partial
thromboplastin time (APT!'), thrombin time (TT), reptilase time,
antithrombin III (AT III) activity and heparin concentrations
were determined using kits from Boehringer Mannheim (Mann-
heim, Germany). The fibrin degradation product D-Dimer was
quantitated with the D-Dimer Elisa by Boehringer Mannheim.
Evaluation of side effects in patients
All patients were interviewed about flush, palmar eiythema,
headache, nausea, pruritus, vomiting, abdominal pain, angina and
erythema.
1115
1116 Baumgartner-Parzer et al: Hemodialysis membranes and adhesion proteins
Statistical evaluation
For all experimental data in different dialysis groups arithmetic
means and standard deviations were calculated. The t-test for
paired numbers was used for statistical evaluations.
In vitro analyses of dialysis capillaries
Two dialysis capillaries were tested in a system which consisted
of (a) Cuprophane hollow fiber dialysis membrane [Cuprophane
(CP), Fresenius MTS, Bad Homburg, Germany, 1.3 m2J or (b)
Polyacrylonitrile membrane [AN 69-12 (PA), Hospal, Niirnberg,
Germany, 1.3 m2] and an extracorporeal dialysis machine, (SPS-
Brady, Vienna, Austria) containing arterial and venous blood
lines (VMP; Achim Schulz-Lauterbach, Iserlohn, Germany).
Blood, drawn from the anticubital vein of young, healthy male
volunteers (27 4 years) with a 15 g needle, was mixed with
unfractionated standard heparin (7 U/ml) and was immediately
used for dialysis experiments. To fill the system, 95 ml blood were
required for the CP and 96 ml for the PA membrane. For the
tubing system 130 ml (pump 40 ml, arteriovenous part 90 ml) were
necessary. The system was preprimed with saline at 37°C for one
hour before it was filled with heparinized blood (225 ml/226 ml).
Arterial and venous blood lines were connected (short circuit),
and then dialysis was started and continued for one hour at 37°C
with 200 ml/min blood flow using Reg concentrate as the dialysis
medium (dialysate flow rate 500 ml/min). An extensive rinsing
step with 1 liter of saline followed to remove any visible residual
blood. Adsorbed material was eluted from the capillaries using a
roller pump. A stepwise elution of the adsorbed material was
carried out using 120 ml each of the following eluants in the given
order: saline (2X); 1 M Tris, pH 7.4; 2% SDS in saline (2x). The
eluants were circulated through the dialysis membrane for 30
minutes, using a flow rate of 600 mI/hr. Then the eluates were
collected, divided into aliquots, frozen and stored at —20°C.
Analysis of eluted materials
Equal size samples of each eluate were submitted to SDS
polyacrylamide (PAA) gel electrophoresis [10]. All samples were
pretreated with either 2% SDS or 2% SDS plus 3.5% f3-mercap-
toethanol (for analysis of fibrinogen). Gels were either stained
with Coomassie brilliant blue or subjected to electroblotting [11,
12]. Unsaturated binding sites on the nitrocellulose membranes
were quenched with dry milk before incubation with the mono-
specific first antibodies, biotinylated second antibodies (protocols
shown in Table 1) and '251-streptavidin. The specificity of the
antibodies was tested by parallel incubations of the blots with
nonimmune sera. Bound radioactivity was detected by autoradiog-
raphy. The autoradiograms were evaluated qualitatively by visual
inspection and quantitatively by densitometry on a Hirschmann
(Elscript 400) densitometer.
Reagents
Antibodies. Polyclonal goat anti-human antibodies (purified
IgG) for fibrinogen, albumin, AT III and IgG F(ab)2 were
purchased from Atlantic Antibodies (Scarborough, USA). Rabbit
anti-goat IgG antibodies, biotinylated, came from Vector (Burl-
ingame, VT, USA). Monoclonal mouse anti-human platelet glyco-
protein lb antibody (CD42b) was purchased from Immunotech
(Marseille, France); Mouse anti-human vitronectin antibody was
from Cytotech (San Diego, CA, USA). Anti-human-PLAI anti-
Table 1. Antibodies and incubation conditions for the immunoblot
procedures
Incubation conditions
.Concentration Incubation
Target antigen Antibodies % time hr temp.
Albumin 1. GaH
2. RaG IgGa
0.30
0.02
8 RT
16 RT
IgG 1. GaH 0.20 8 RT
Fibrinogen
Vitronectin
2. RaG IgGa
1. GaH
2. RaG IgG°
1. MaH
2. 1I-SaM IgGa
0.02
0.30
0.02
0.13
16 RT
8 RT
16 RT
16 4°C
2 4°C
AT III 1. GaH
2. RaG IgGa
0.30
0.02
8 RT
16 RT
GP lIb/Illa 1. HaH
2. 125j -GaH IgG"
0.01 16 4°C
2 4°C
GP lb 1. MaH
2. 1251-SaM IgG"
0.05 16 4°C
2 4°C
Abbreviations are: Temp. temperature; G, goat; H, human; M, mouse;
R, rabbit; S, sheep; RT, room temperature.
These second antibodies were biotinylated. Detection of biotinylated
antibodies was achieved by incubation with 1251-streptavidin, usually in
concentrations of 0.06 uCi/mI incubation solution.b
'251-labeled second antibodes were generally used in concentrations of
0.1 Ci/ml.
body, identified in the serum of a patient with post-transfusional
purpura [13], was a gift of Dr. S. Panzer.
Radiolabeled substances. 1251-streptavidin and 1251-sheep anti-
mouse IgG was from Amersham (Amersham Place, UK); 125J
goat anti-human IgG was from ICN (Irvine, CA, USA).
Hemodialysis reagents. Saline and Duoflac was from Leopold &
Co. (Graz, Austria). Reg-dialysate contained the following com-
ponents: Na 140, K 2.0, Ca 3.5, Mg 1.5, CH3COO 35.0,
Cl 112.0 (all concentrations are given in millival), and glucose
1.82 g/liter, total osmolarity 301 mOsm.
Blood samples. All blood samples, obtained from normal blood
donors, had normal hematocrit, and normal levels of total plasma
protein, albumin, IgG, fibrinogen, AT III, C3 and C4 and were
platelet antigen PL Al positive. All parameters were determined
by routine methods.
Results
Patient study
In patients, who were dialyzed with CP membranes, higher
concentrations of the fibrin degradation product D-Dimer were
found than in patients dialyzed with PA membranes (Fig. 1). The
difference was significant (P < 0.001).
Heparin increased continously in plasmas of patients dialyzed
with PA dialyzers (from 30 mm to 4 hr). Upon dialysis with CP
membranes little increase was observed, and the difference was
significant (Fig. 2).
In vitro system
Stained SDS-PAGE exhibited differences in the protein com-
position and concentration of the PA and CP eluates (Fig. 3 A, B).
A protein with a molecular weight of 48 kD was observed in all
eluates. Its concentration was highest in the first saline eluate of
the PA capillaries and the first and second saline eluates of the CP
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membranes. Proteins were eluted by treatment of the PA mem-
branes with SDS, which were neither detectable in the other
eluates of this membrane, nor in the eluates of the CP capillaries.
By immunoblotting (Table 2) a protein, which was recognized
by albumin antibodies and migrated with the same electrophoretic
mobility as plasma albumin, was identified in all eluates. All
eluates contained low molecular weight albumin analogs (35 kD to
40 kD) and, except the two Tris and the first SDS PA eluate, all had
also high molecular weight (70 kD to 200 kD) albumin derivatives.
Albumin (intact form, low and high molecular weight form) in the
CP eluates amounted to 69% of the concentration in PA eluates.
All Cuprophane and Polyacrylonitrile eluates contained a pro-
tein which reacted with the anti-IgG antibody. The molecular
weight of the protein was the same as for purified IgG and IgG in
normal plasma. PA eluates contained 1.4 times more intact IgG
material than CP eluates. Low molecular weight products reacting
with the IgG antibody were only found in the Tris and SDS eluates
of the PA membrane.
The eluates of both membranes contained material which
migrated with the same electrophoretic mobility as intact fibrin-
ogen in normal plasma (50 to 68 kD), as well as low molecular
weight forms (25 to 40 kD) of fibrinogen. In CP eluates only 26%
of the amount found in PA eluates was present. However, in CP
eluates 1.2 times more low molecular weight product than intact
fibrinogen was identified, while in PA eluates the concentration of
both forms was about the same.
Intact vitronectin as well as low (43 to 48 kD) and high (68 to
200 kD) molecular weight derivatives could only be detected in
Tris and SDS eluates of the PA membranes (Fig. 4). The highest
concentration was detectable in the first SDS eluate.
A protein corresponding to AT III was found in all Cuprophane
and PA eluates. High molecular weight AT III containing prod-
ucts were present in the first saline eluates of both membranes.
More AT III was eluted by saline from CP membranes compared
to PA capillaries, while Tris buffer or SDS eluted more AT III
material from PA dialyzers than from CP membranes.
GP lb and GP Jib/lila could not be identified in any of the
eluates.
Discussion
Adsorption of proteins onto foreign surfaces (for example,
hemodialysis membranes) is one of the initial events occurring
upon contact of blood with artificial surfaces. It has been shown
that the composition of the protein layers is largely determined by
the surface material [14—17]. However, for most components it is
still unclear whether their adsorption has positive or negative
effects on subsequent processes such as adhesion of platelets or
activation of the coagulation and complement system. The com-
plexity of reactions and interactions taking place upon contact of
blood with artificial surfaces and the variety of experimental
designs and systems used to evaluate biocompatibility of hemodi-
alysis membranes make conclusive interpretations vesy difficult.
In our study, we analyzed proteins in eluates of two dialysis
membranes and could demonstrate significant differences of the
protein adsorption properties of these capillaries. Some proteins
may have escaped elution and thus could not be evaluated.
However, other systems also may not permit complete evaluation
of all components affected by the contact of blood with foreign
surfaces during hemodialysis. The data we obtained for fibrinogen
were especially interesting. From PA membranes half of the
eluable fibrinogen migrated with the mobility of the native form,
and the other half had lower molecular weight. The CP eluates
contained higher amounts of fibrinogen in low molecular weight
form than in the native form. Taking all eluates together, four
times more fibrinogen-like material could be eluted from PA than
from CP membranes. The amount of albumin which was eluted
from PA was only 1.4 times higher than that eluted from CP
capillaries. The amount of IgG which could be removed from PA
was twice as high as from CP.
Assuming that the amount of a protein recovered in the eluates
reflects the concentration of this component on the surface,
clearly more fibrinogen must have been bound to PA than to CP.
However, not only the quantitative but also the qualitative
evaluation of the protein composition in the eluates can give
important insights into reactions occurring during dialysis. In the
CP eluates more of the fibrinogen-like proteins were present in a
low molecular weight form. This may represent fibrinolytic deg-
radation products. Interestingly, analyses of patient plasmas
showed significantly higher D-Dimer concentrations after dialysis
with CP than with PA capillaries.
The microscopic evaluations of CP and PA capillaries clearly
indicated the presence of fibrin deposits on CP but not PA
capillaries [18]. These fibrin deposits surrounded activated throm-
bocytes (with pseudopodia) which were also not found on PA
2000
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Fig. 1. Levels of FD-dimers during CP (U) and PA () hemodialysis. FD
dimers were measured pre-hemodialysis (T0), 30 mm (Ti), 120 mm (T2)
and at the end of hemodialysis (T1). The increase of FD dimers during CP
versus PA hemodialysis was significant (P < 0.001).
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Fig. 2. Course of heparin concentration during CP (U) and PA ()
hemodialysis. A significant difference (P < 0.05) of heparin concentration
was found at 120 mm after start (T2) of hemodialysis and at the end of
hemodialysis (240 to 270 mm, T3) in PA versus CP membranes.
TO Ti T2 T3
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A
Fig. 3. A. SDS-PAGE of CP eluates. Samples were prepared for electro-
phoresis as described in the Methods, separated on 7.5% gels and stained
with Coomassie Brilliant Blue. Aliquots of 230 jLl of nonreduced samples
were applied to each lane in the following order: (1) first saline eluate, (2)
second saline eluate, (3) Tris eluate, (4) first SDS eluate, (5) second SDS
eluate. B. SDS-PAGE of PA eluates. Preparations were the same as for
CP eluates.
membranes. Possibly the adsorption of thrombocytes to PA is
prevented by the higher concentrations of albumin on PA (Table
2). In vitro studies using various artificial surfaces have shown that
the presence of albumin can reduce platelet adhesion to artificial
surfaces [19]. A most interesting finding of our study was the
detection of high concentrations of vitronectin in the PA eluates,
while no vitronectin could be eluted from CP membranes. The
elution from PA could only be achieved by 2% SDS, which
suggests a tight binding of vitronectin to PA membranes.
Vitronectin, which functions as adhesive protein [20, 21], is also
capable of regulating and modulating the coagulation and fibrino-
lytic system. Vitronectin forms complexes with plasminogen acti-
vator inhibitor (PAl-i) [22—24], and stabilizes and preserves
PAl-I as a functionally active inhibitor of thrombin [25] and tissue
plasminogen activator (tPA) [26, 27]. Possibly vitronectin also
binds and stabilizes PAl-i on the surface of PA membranes and
thus controls plasmin generation during dialysis with PA capillar-
ies. Our finding of low concentrations of D-Dimer in patients
dialyzed with PA membranes would be supportive for the above
speculation. However, we cannot exclude that significantly lower
D-Dimer levels observed in the plasmas of patients dialyzed with
PA capillaries are due to a higher clearance.
Surprisingly, we observed a continous increase of free heparin
in patients' plasmas during dialysis with PA membranes, which
1 2 3 4 5
2
kd
200
3 4 5
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Table 2. Adsorption of proteins on CP and PA hemodialysis
membranes (60 mm dialysis time)
Protein
Eluates
Molecular
wt
2"
Saline Saline
PA CP PA CP
Tris
PA CF
1st
SDS
PA CP
2nd
SDS
PA CP
Albumin 60
35—40
70—200
90 54 38 443 3 <1 2
27 28 13 18
49 3410 1
— —
47 36
16 1
— 7
51 20
14 <17 5
IgG 200 176 196 12 10 13 1 61 6 41
Fibrinogen
160—200
50_68a
25—40
— — — —
133 40 44 21
58 36 33 33
4 —
106 17
74 39
100 —
152 31
231 37
83 —
142 22
206 30
Vitronectin 58_62a
43—48
68—200
— — — — — —
—
—
—
—
—
AT III 45_52a
120
30 37 4 15
5 7
15 3 18 5 17 2
Fig. 4. Vitronectin immunoblot of PA eluates. Samples were prepared for
electrophoresis as described in the Methods. Nonreduced samples were
separated on 7.5% gels. The aliquots (200 jLl) were applied in the
following order: Lanes I to 3, PA eluates (1, Tris eluate; 2, first SDS
eluate; 3, second SDS eluate); and Lane 4, normal plasma, diluted 1:500.
plexed, such as to AT Ill-thrombin complexes generated in
plasmas dialyzed with CP membranes. Preliminary data indicate
that the high molecular weight AT III derivatives, detected in CP
eluates, are TAT complexes. As the heparin assay used can only
detect free heparin, complexed heparin was not measured.
However, more data are necessary to prove these speculations.
In the clinical setting the in vitro data are confirmed by the finding
of less fibrin and higher heparin concentrations in plasmas
dialyzed with PA membranes.
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